ResMed delivered another impressive performance in the third quarter of fiscal 2013. Revenue rose 10% to USD 384 million, operating income increased 26% to USD 96.1 million and net income was 31% higher at USD 84.9 million. Diluted earnings per share rose 32% to USD 0.58 and over the nine months to 31 March 2013 are 36% higher than in the corresponding nine months in … Continue reading ResMed Sees Impressive Growth in Q3